Hjem › Major depresjon › New York
Kliniske studier for Major depresjon i New York
48 studier for Major depresjon søker deltakere på steder i New York.
Byer i New York
Offisiell studietekst (engelsk)
A Study of Brenipatide (LY3537031) in Adult Participants With Major Depressive Disorder
- Adams Clinical Bronx, The Bronx
RekruttererFase 3
Alder 18 til 75 · Alle kjønn · Oppdatert 1. okt. 2026 · NCT07775300A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder
- Integrative Clinical Trials LLC, Brooklyn
- SPRI Clinical Trials, LLC, Brooklyn
- Bioscience Research LLC, Mount Kisco
- og 3 flere
RekruttererFase 3
Alder 18 til 74 · Alle kjønn · Oppdatert 1. okt. 2026 · NCT07573176Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms
- Integrative Clinical Trials LLC, Brooklyn
- SPRI Clinical Trials, LLC, Brooklyn
- Bioscience Research LLC, Mount Kisco
- og 1 flere
RekruttererFase 3
Alder 18 til 74 · Alle kjønn · Oppdatert 25. sep. 2026 · NCT06559306A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)
- Ima Clinical Research - Nyc Midtown, New York
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 25. sep. 2026 · NCT07621237Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder
- SPRI Clinical Trials, LLC, Brooklyn
- Manhattan Behavioral Medicine, New York
RekruttererFase 3
Alder 18 til 65 · Alle kjønn · Oppdatert 25. sep. 2026 · NCT05850689A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
- Adams Clinical Harlem, New York
- New York State Psychiatric Institute, New York
- Davis Clinical (Adams Clinical Bronx), The Bronx
- og 1 flere
RekruttererFase 3
Alder 18 til 85 · Alle kjønn · Oppdatert 25. sep. 2026 · NCT06793397Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive Disorder
- Vanda Investigational Site, New York
- Vanda Investigational Site, New York
- Vanda Investigational Site, Staten Island
RekruttererFase 3
Alder 18 til 65 · Alle kjønn · Oppdatert 24. sep. 2026 · NCT06830044DBS for TRD With the Medtronic Percept PC
- Icahn School of Medicine at Mount Sinai, Mount Sinai West, New York
Rekrutterer
Alder 25 til 70 · Alle kjønn · Oppdatert 22. sep. 2026 · NCT05773755Pattern Separation in Major Depressive Disorder
- New York State Psychiatric Institute (NYSPI), New York
RekruttererFase 1
Alder 18 til 50 · Alle kjønn · Oppdatert 15. sep. 2026 · NCT07139834A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)
- Seaport Investigator Site, Brooklyn
- Seaport Investigator Site, Cedarhurst
- Seaport Investigator Site, New York
- og 1 flere
RekruttererFase 2
Alder 18 til 65 · Alle kjønn · Oppdatert 14. sep. 2026 · NCT07065240ACP-211 Monotherapy for Major Depressive Disorder With Inadequate Antidepressant Response
- Integrative Clinical Trials LLC, Brooklyn
RekruttererFase 2
Alder 18 til 65 · Alle kjønn · Oppdatert 14. sep. 2026 · NCT07284667A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)
- Bioscience Research, LLC, Mount Kisco
- Fieve Clinical Research, Inc., New York
- IMA Clinical Research, New York
RekruttererFase 3
Alder 18 til 74 · Alle kjønn · Oppdatert 8. sep. 2026 · NCT07076407A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression
- Draig Clinical Site, New York
- Draig Clinical Site, New York
RekruttererFase 2
Alder 18 til 75 · Alle kjønn · Oppdatert 2. sep. 2026 · NCT07610473Treatment ResistAnt Depression Subcallosal CingulatE Network DBS (TRANSCEND)
- Mount Sinai Hospital, New York
Rekrutterer
Alder 22 til 70 · Alle kjønn · Oppdatert 28. aug. 2026 · NCT06423430A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression
- Draig Clinical Site, New York
RekruttererFase 2
Alder 18 til 75 · Alle kjønn · Oppdatert 26. aug. 2026 · NCT07300969NBI-1065845-MDD3025: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, New York
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 11. aug. 2026 · NCT06911112A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)
- Adams Clinical Harlem, New York
RekruttererFase 3
Alder 18 til 74 · Alle kjønn · Oppdatert 10. aug. 2026 · NCT07592689NBI-1065845-MDD3026: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, Cedarhurst
- Neurocrine Clinical Site, New York
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 10. aug. 2026 · NCT06963021A Study of Brenipatide in Adult Participants With Major Depressive Disorder
- Adams Clinical Harlem, New York
RekruttererFase 3
Alder 18 til 75 · Alle kjønn · Oppdatert 6. aug. 2026 · NCT07412756A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder
- Integrative Clinical Trials, Brooklyn
- Richmond Behavioral Associates, Staten Island
RekruttererFase 3
Alder 18 til 74 · Alle kjønn · Oppdatert 3. aug. 2026 · NCT06775379Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder
- Neurobehavioral Research, Inc., Cedarhurst
RekruttererFase 2
Alder 18 til 64 · Alle kjønn · Oppdatert 3. aug. 2026 · NCT06547489A Phase 2 Study of Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder
- Neurobehavioral Research, Inc, Cedarhurst
- IMA Clinical Research - NYC Midtown, New York
- IMA Clinical Research - NYC Uptown, New York
RekruttererFase 2
Alder 18 til 64 · Alle kjønn · Oppdatert 27. jul. 2026 · NCT07115329A Study to Evaluate the Maintenance Effect of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, Glen Oaks
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 24. jul. 2026 · NCT07196501Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, Cedarhurst
- Neurocrine Clinical Site, Mount Kisco
- Neurocrine Clinical Site, New York
- og 2 flere
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 24. jul. 2026 · NCT06966401Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol
- Clinical Research Site, Brooklyn
- Clinical Research Site, New York
- Clinical Research Site, New York
- og 2 flere
RekruttererFase 3
Alder 18 til 65 · Alle kjønn · Oppdatert 24. jul. 2026 · NCT07484217Feasibility of Home-Based Intermittent 60Hz Light Therapy for Major Depressive Disorder (MDD)
- NYU Langone Health, New York
Rekrutterer
Alder 24 til 65 · Alle kjønn · Oppdatert 29. jun. 2026 · NCT07111390A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder
- Ima Clinical Research - Manhattan /ID# 278212, New York
- Manhattan Behavioral Medicine /ID# 277910, New York
RekruttererFase 2
Alder 18 til 65 · Alle kjønn · Oppdatert 15. jun. 2026 · NCT07276997tDCS: Sleep to Mood in Depression (S2M-D)
- NYU Langone Health, New York
Rekrutterer
Alder 18 til 65 · Alle kjønn · Oppdatert 8. jun. 2026 · NCT07572526Triage Survey for Psychiatry Research Eligibility
- Adams Clinical, Harlem, New York
- Adams Clinical, Bronx, The Bronx
RekruttererObservasjonsstudie
Alder 18 og eldre · Alle kjønn · Oppdatert 20. mai 2026 · NCT05800925A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)
- The Medical Research Network, LLC, New York
RekruttererFase 2
Alder 18 til 65 · Alle kjønn · Oppdatert 11. mai 2026 · NCT06524830Aβ Dynamics in LLMD
- NYU Langone Health, New York
- Nathan S. Kline Institute for Psychiatric Research, Orangeburg
RekruttererFase 4
Alder 60 og eldre · Alle kjønn · Oppdatert 6. mai 2026 · NCT05004987Mindfulness-Based fMRI Neurofeedback for Depression
- Columbia University Irving Medical Center, New York
Rekrutterer
Alder 13 til 18 · Alle kjønn · Oppdatert 29. apr. 2026 · NCT05617495Neutralizing Interleukin (IL)-6
- Icahn School of Medicine at Mount Sinai, New York
RekruttererFase 2Frivillige helsepersonell ønskes velkommen
Alder 18 til 70 · Alle kjønn · Oppdatert 29. apr. 2026 · NCT07493317Maintenance rTMS for Depression (Maitr-De)
- Weill Cornell Medicine, New York
Rekrutterer
Alder 18 til 80 · Alle kjønn · Oppdatert 29. apr. 2026 · NCT06938841Brain Changes During Social Reward Psychotherapy for Mid- and Late-Life Suicidality
- Weill Cornell Medicine, New York
Rekrutterer
Alder 50 til 80 · Alle kjønn · Oppdatert 27. mar. 2026 · NCT05925322Biomarker-guided rTMS for Treatment Resistant Depression
- Weill Cornell Medicine, New York
RekruttererFase 3
Alder 22 til 65 · Alle kjønn · Oppdatert 25. feb. 2026 · NCT04041479The Role of mGluR5 in CBT-I
- Stony Brook University: Dept of Psychiatry, Stony Brook
RekruttererFase 4
Alder 18 og eldre · Alle kjønn · Oppdatert 17. feb. 2026 · NCT07076342Transcranial Near Infrared Radiation and Cerebral Blood Flow in Depression - R33
- NYU Langone Health, New York
- Nathan Kline Institute for Psychiatric Research, Orangeburg
Rekrutterer
Alder 18 til 65 · Alle kjønn · Oppdatert 5. feb. 2026 · NCT05573074Study of ABX-002 for the Adjunctive Treatment of Major Depressive Disorder (AMPLIFY)
- Autobahn Site #105, Brooklyn
- Autobahn Site #134, Brooklyn
- Autobahn Site #104, Staten Island
RekruttererFase 2
Alder 18 til 65 · Alle kjønn · Oppdatert 20. jan. 2026 · NCT06633016Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, Mount Kisco
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 29. okt. 2025 · NCT06786624Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.